 |
NYON, Switzerland, March 4, 2021 /PRNewswire/ -- MedAlliance, the first drug-eluting balloon (DEB) company in the world to receive US Food and Drug Administration (FDA) Breakthrough Device Designation Status for a sirolimus DEB, has now been awarded breakthrough status for SELUTION SLR™, its sustained limus release DEB catheter, in the...
For publishers and advertisers, a successful affiliate partnership begins with the right audience, clear terms and a shared...
Peru is making a direct play to attract $92 billion in untapped Australian investment, technology and critical minerals par...
“Get your website to number one on Google.” It is an appealing sales pitch. For a business owner trying to attract custome...
Harmony’s proprietary, task-specific LLMs respond in about 200 milliseconds and produce a contact ra...
A Brisbane-based online marketplace is taking a different approach to buying and selling: everything...
Harmony’s proprietary, task-specific LLMs respond in about 200 milliseconds and produce a contact ra...
On opposite sides of Australia, two celebrated coastal destinations face a shared challenge: maint...
For publishers and advertisers, a successful affiliate partnership begins with the right audience...
Food, shelter, safety and schooling are essential. But the guidance children receive about how to ...
Australia’s housing divide is increasingly about what remains after the housing bill is paid. A h...